Original Article

CME Article: Risk of Silent Myocardial Infarction in Prediabetic Patients: A Case-Control Study in a Veteran Population

Authors: Eknath Naik, MD, PhD, Deepa Dongarwar, MS, Fabio Leonelli, MD, Philip Foulis, MD, MPH, Paul Leaverton, PhD, Christine Le, MD, Deepika Kulkarni, MD, Koushik Reddy, MD, Amy Alman, PhD, Phong Ong, MD, Adam Zoble, MS, Hamisu M. Salihu, MD, PhD


Objectives: In the management of cardiovascular disease, it is important to identify patients at risk early on, to provide interventions to prevent the disease and its complications. The goal of our study was to investigate the association between glucose levels and silent myocardial infarction (SMI) among patients, who consisted of veterans within the Veterans Affairs clinical system.

Methods: Among the group of patients with an initially normal electrocardiogram, a cohort of patients with a subsequent diagnosis of SMI was selected as the case cohort, whereas 4 patients for each study subject, without evidence of coronary artery disease and normal electrocardiogram within the previous 6 months, were identified and constituted the control cohort. We conducted an adjusted logistic regression model using the stepwise function to assess the association between glucose level and SMI.

Results: Of the 540 patients included in the study, 108 (20.0%) with an SMI diagnosis made up the case cohort. We observed that as compared with those who had normal levels of glucose, those who were prediabetic were 3.99 times as likely (95% confidence interval 1.48–12.85) to have SMI, whereas the diabetic patients were 3.80 times as likely (95% confidence interval 1.39–12.38) to experience SMI.

Conclusions: SMIs have been shown to be predictive of subsequent cardiovascular events, including another MI and death, and that indicates the importance of identifying a group at high risk for a SMI. As such, our findings could be extremely beneficial for targeted intervention toward prediabetics and to improve health outcomes in the entire population.
Posted in: Cardiovascular Disease21 Endocrinology, Diabetes, and Metabolism22

This content is limited to qualifying members.

Existing members, please login first.

If you have an existing account please login now to access this article or view your purchase options.

Purchase only this article ($15)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.


1. Scirica BM. Prevalence, incidence, and implications of silent myocardial infarctions in patients with diabetes mellitus. Circulation 2013;127:965–967.
2. Kannel WB, Sorlie P, McNamara PM. Prognosis after initial myocardial infarction: the Framingham study. Am J Cardiol 1979;44:53–59.
3. DeLuca AJ, Kaplan S, Aronow WS, et al. Comparison of prevalence of unrecognized myocardial infarction and of silent myocardial ischemia detected by a treadmill exercise sestamibi stress test in patients with versus without diabetes mellitus. Am J Cardiol 2006;98:1045–1046.
4. Ahmed AH, Shankar K, Eftekhari H, et al. Silent myocardial ischemia: current perspectives and future directions. Exp Clin Cardiol 2007;12:189–196.
5. WebMD. Prediabetes (borderline diabetes). https://www.webmd.com/dia betes/what-is-prediabetes. Published 2020. Accessed August 20, 2020.
6. Centers for Disease Control and Prevention. National Diabetes Statistics Report, 2017. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2017.
7. Nasr G, Sliem H. Silent myocardial ischemia in pre-diabetics in relation to insulin resistance. J Cardiovasc Dis Res 2010;1:116–121.
8. Davis TM, Coleman RL, Holman RR. Prognostic significance of silent myocardial infarction in newly diagnosed type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 79. Circulation 2013;127:980–987.
9. Stacey RB, Zgibor J, Leaverton P, et al. Abnormal fasting glucose increases risk of unrecognized myocardial infarctions in an elderly cohort. J Am Geriatr Soc 2019;67:43–49.
10. Acharya T, Aspelund T, Jonasson T, et al. Association of unrecognized myocardial infarction with long-term outcomes in community-dwelling older adults. JAMA Cardiol 2018;3:1101.
11. Øhrn A, Nielsen C, Schirmer H, et al. Pain tolerance in persons with recognized and unrecognized myocardial infarction: a population-based, cross-sectional study. J Am Heart Assoc 2016;5:e003846.
12. Thygesen K, Alpert J, Jaffe A, et al. Fourth Universal Definition of Myocardial Infarction (2018). Glob Heart 2018;13:305–338.
13. Intzilakis T, Mouridsen MR, Almdal TP, et al. Impaired fasting glucose in combination with silent myocardial ischaemia is associated with poor prognosis in healthy individuals. Diabet Med 2012;29:e163–e169.
14. Scheidt-Nave C, Barrett-Connor E, Wingard DL. Resting electro-cardiographic abnormalities suggestive of asymptomatic ischemic heart disease associated with non-insulin-dependent diabetes mellitus in a defined population. Circulation 1990;81:899–906.
15. Hadaegh F, Ehteshami-Afshar S, Hajebrahimi MA, et al. Silent coronary artery disease and incidence of cardiovascular and mortality events at different levels of glucose regulation; results of greater than a decade follow-up. Int J Cardiol 2015;182:334–339.
16. Lundblad D, Eliasson M. Silent myocardial infarction in women with impaired glucose tolerance: the Northern Sweden MONICA study. Cardiovasc Diabetol 2003;2:9.
17. Nadour W, Doyle M, Williams RB, et al. Does the presence of Q waves on the EKG accurately predict prior myocardial infarction when compared to cardiac magnetic resonance using late gadolinium enhancement? A cross-population study of noninfarct vs infarct patients. Heart Rhythm 2014;11:2018–2026.